1 – 8 of 8
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
- 2010
-
Mark
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
(
- Contribution to journal › Article
-
Mark
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
(
- Contribution to journal › Article
- 2008
-
Mark
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
(
- Contribution to journal › Article
- 2007
-
Mark
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
(
- Contribution to journal › Article
- 2005
-
Mark
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis - The EVIDENCE study
(
- Contribution to journal › Article
- 2001
-
Mark
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
(
- Contribution to journal › Article
- 1989
-
Mark
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
(
- Contribution to journal › Article